This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.

Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Julio Rosenstock
Dr Julio
Rosenstock
University of Texas Southwestern Medical Center, Dallas, USA

Dr. Julio Rosenstock is Director of Velocity Clinical Research at Medical City Dallas and Clinical Professor of Medicine at the University of Texas Southwestern Medical Center, Dallas, USA. 

 

He received his MD from the University of Costa Rica School of Medicine, and completed fellowships in endocrinology and diabetes at the Royal Postgraduate Medical School, Hammersmith Hospital, London, UK and at the University of Texas Southwestern Medical Center, Dallas, USA. He is board certified in internal medicine, endocrinology and metabolism. 

 

His clinical and research activities have focused on exploring novel agents and therapeutic strategies to improve glycemic control, particularly early combination therapies in type 2 diabetes. He has participated in hundreds of clinical trials and has been involved in developing new oral and injectable agents and insulin preparations, often acting as a lead clinical investigator and scientific advisor on the design and reporting of clinical trials on novel diabetes drugs.

 

He has authored or co-authored 360 peer-reviewed manuscripts (H-index 119) and hundreds of scientific abstracts and contributed to 13 book chapters on various diabetes topics. He is considered a key opinion leader in type 2 diabetes and has chaired or been a featured speaker at multiple lectures and presentations globally.

Speaker - Monika Kellerer

Professor Monika Kellerer

Department of Diabetology and Endocrinology, Angiology, Intensive Care Unit, Cardiology Marienhospital Stuttgart, Stuttgart, Germany


Professor Dr Monika Kellerer is Professor of Internal Medicine and Director of the Department of Diabetology, Endocrinology, Angiology, Intensive Care Unit and Cardiology at Marienhospital Stuttgart, a teaching hospital of the University of Tübingen, Germany.

 

She earned her MD degree from Ludwig-Maximilians University, Munich, Germany and her PhD (habilitation thesis) from Eberhard Karls University, Tübingen, Germany. She completed a post-doctoral fellowship at the Joslin Diabetes Center, Harvard Medical School, Boston, USA. She is board certified in endocrinology, diabetology and internal medicine by the German Physician Board.

 

She is 2021–2023 Senior President and Guideline Coordinator of the German Diabetes Association (DDG), and a member of the DDG board on scientific statements and healthcare policy. Her research interests are clinical diabetology, the insulin signalling mechanism, specific effects of insulin analogues, mechanisms of lipotoxicity and beta cell dysfunction. She is also involved in clinical research for diabetes as a national lead investigator.

 

She is the recipient of prestigious awards including the Förderpreis of the DDG (1992), the Ferdinand Bertram Award (1996) and the Helmut Otto Medal (2015). She has published numerous articles in medical literature and is the author or co-author of several books and book chapters in the field of diabetes.


Read full bio